drugset / Trial / NCT00080119

Summary

Tuberculosis (TB) is highly endemic in sub-Saharan Africa. The increased burden of TB in settings with high prevalence of the Human Immunodeficiency Virus (HIV) is associated with high rates of transmission of Mycobacterium tuberculosis (M.tb) to both adults and children. Children infected with TB have a higher risk of developing severe disease than adults with TB. The purpose of this study was to determine if the antibiotic isoniazid (INH) prevented TB infection in infants born to HIV-infected mothers.

Timeline

Start
2004-02
Primary completion
2009-05
Completion
2009-05

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Isoniazid Small molecule 10 mg/kg Oral
Subject Isoniazid Small molecule 20 mg/kg Oral
Background Trimethoprim/Sulfamethoxazole Unknown 5 mg/kg Oral